SUPPORT for Patients and Communities Reauthorization Act

The SUPPORT for Patients and Communities Reauthorization Act reauthorizes and amends various programs related to substance use disorder prevention, treatment, recovery, and technical corrections. It extends funding and modifies provisions across multiple titles of the Public Health Service Act and the SUPPORT for Patients and Communities Act.

Title I, Prevention: This title extends surveillance and education programs for infections from illicit drug use through 2028, amends first responder training to cover all substances causing overdose, and updates the National Child Traumatic Stress Initiative. It also authorizes grants for preventing adverse childhood experiences, clarifies funds can be used for overdose prevention products, supports individuals with fetal alcohol spectrum disorders, and promotes state choice in prescription drug monitoring programs. It requires guidance on at-home drug disposal systems and a review of opioid drugs, and adds requirements for electronic prescribing of controlled substances under health plans starting in 2026.

Title II, Treatment: This title reauthorizes the residential treatment program for pregnant and postpartum women, increases loan repayment funding for substance use disorder treatment workforce to $50 million annually from 2024 through 2028, and authorizes specific appropriations for mental health education and training. It removes a subsection on regional centers of excellence, modifies grants for trauma support in schools, and requires final regulations on telemedicine registration for controlled substances. It also mandates reports on mental health parity and state guidance on serious mental illness, and establishes a pilot program for peer-to-peer mental health support in schools.

Title III, Recovery: This title expands youth prevention and recovery programs to include consortia of local educational agencies and secondary schools, increases funding for building communities of recovery to $16 million annually from 2024 through 2028, and expands the peer support technical assistance center. It establishes an Office of Recovery within the Substance Abuse and Mental Health Services Administration and requires a report on criminal background checks for peer support specialists and a public meeting on improving access to federal funding opportunities.

Title IV, Technical Amendments: This title makes technical corrections to the Controlled Substances Act, including allowing pharmacies to deliver schedule III, IV, or V controlled substances for intranasal administration under a risk evaluation and mitigation strategy, correcting a cross-reference, and requiring training for prescribers of controlled substances.